New Market Study, "Adaptive Biotechnologies Corporation - Product Pipeline Analysis, 2013 Update", Has Been Published
Adaptive Biotechnologies Corporation (Adaptive) is a biotechnology company. The company develops next generation sequencing assays for the adaptive immune system. It offers immunoSEQ, a suite of immune profiling assays coupled with cloud-based analyzation software that permits researchers to characterize the immune repertoire of a patient or group of patients in search of immunologic biomarker. Adaptive offers research and diagnostic tools for scientists, doctors, and clinicians. Its clients include University of Cambridge, Charles University in Prague, Cleveland Clinic, IMI University center,...
View full press release